France investigating Renault on suspicion of emissions fraud
French authorities are investigating carmaker Renault in connection with suspected fraud in its diesel emissions controls, denting the company’s share price as the global fallout spreads from revelations of emissions cheating at Volkswagen.
Renault insisted Friday that its cars are not equipped with pollution-cheating software, and that the company complies with all French and European laws.
Shares in partially state-owned Renault — one of France’s leading manufacturers — fell 2.9% on Friday.
The Paris prosecutor’s office said three investigating judges have opened a judicial inquiry into Renault’s emissions controls practices and whether they “made merchandise dangerous for human health.”
The probe is based on an initial investigation by the Economy Ministry’s fraud department, which handed its findings to prosecutors in November.
Renault-Nissan Chief Executive Carlos Ghosn has said that despite the Volkswagen scandal, the company will continue developing diesel technology, particularly for SUVs and other high-end cars.
In a statement Friday, Renault took note of the investigation, but said its “vehicles are not equipped with cheating software affecting anti-pollution systems.” It said the company supports European moves to toughen emissions testing and has taken steps to reduce its own cars’ emissions over the last year.
French prosecutors are carrying out a separate probe into Volkswagen’s emissions practices in France.
Tentacles of the Volkswagen scandal are continuing to reach across the industry more than a year later: The U.S. government accused Fiat Chrysler on Thursday of failing to disclose software in some vehicles that allows them to emit more pollution than allowed.
2:10 p.m.: This article was updated with Renault shares’ closing price.
This article was originally published at 6:20 a.m.
Your guide to our new economic reality.
Get our free business newsletter for insights and tips for getting by.
You may occasionally receive promotional content from the Los Angeles Times.